Genentech's Lessons For Big Pharma
How does Genentech do it? The biotech company focuses on science — not marketing, acquisitions, or patents
Get updates by email
Editor
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
and Share
Reading
Translator
← Brand Drug Prices Outpace Inflation (previous entry)
(next entry) Giving The Green Light To Industrial Biotech →
© Copyright - BiotechBlog — A thinkBiotech product
Leave a Reply
Want to join the discussion?Feel free to contribute!